Imagine getting a small cut or a bug bite. Most of the time, it heals and fades. But for some people, the scar grows thick, hard, and painful. It can spread beyond the original wound. This is a keloid scar. It can be itchy, tight, and sometimes even limit movement.
Now, imagine a scar that keeps growing for months or even years. It’s not just a cosmetic issue. It can affect your quality of life. Current treatments often fall short. Surgery alone has a high chance of the scar coming back, sometimes worse than before.
Keloids are chronic inflammatory fibroproliferative disorders. In plain English, they are scars that grow too much and don’t stop. They form when the body’s normal wound healing process goes into overdrive. The inflammatory and proliferative phases of healing get stuck in the “on” position.
This leads to an excessive buildup of collagen and other proteins in the skin. The result is a raised, firm scar that grows beyond the original wound’s edges. It’s a common problem, especially in people with darker skin tones. It can be physically uncomfortable and emotionally distressing.
Current treatments include surgery, radiation, and injections directly into the scar. But recurrence rates are high. The problem is that we haven’t fully understood why these scars form and persist. This new review suggests a key piece of the puzzle has been overlooked.
The Surprising Shift
For years, the focus has been on the immune system and genetics. We knew inflammation was a major player. But this new thinking adds a physical dimension: mechanical force.
Think about a piece of tape on your skin. If you pull the edges of the skin together, the tape holds it tight. That tension is a mechanical force. Now, imagine that tension is constant. It doesn’t let up.
Here’s the twist: This constant tension isn’t just a side effect of the scar. It might be a driving force behind it.
How Tension Fuels the Fire
Let’s use an analogy. Imagine a factory that makes bricks (collagen). In normal healing, the factory makes just enough bricks to repair a wall. Then it shuts down.
In keloid formation, the factory never shuts off. The “on” switch is stuck. This new review suggests that mechanical tension is like a hand constantly pressing that “on” switch.
How does it work? The skin cells that make collagen (fibroblasts) have sensors. They can feel tension. When they sense constant pulling, they activate pathways that tell them to make more bricks. At the same time, this tension attracts immune cells that release inflammatory signals.
This creates a vicious cycle. The tension causes inflammation. The inflammation causes more scar tissue. The scar tissue creates more tension. It’s a self-amplifying loop. The review calls it a “mechanical force–inflammation–fibrosis” positive feedback loop.
This review looked at existing research on keloids. It didn’t conduct a new experiment on patients. Instead, it summarized what many studies have found.
The researchers found that keloids are not just a skin problem. They are a complex interaction between the body’s physical environment and its immune system.
Key findings include:
- Immune cells are key players: Cells like M2 macrophages and Th2/Th17 cells flood the area with inflammatory signals. They keep the healing process going long after it should have stopped.
- Mechanical forces are a major driver: High-tension areas of the body (like the chest, shoulders, and jawline) are more prone to keloids. This isn’t a coincidence.
- The two systems talk to each other: Mechanical forces and inflammation are not separate. They are in constant communication, creating a cycle that’s hard to break.
This doesn’t mean this treatment is available yet.
Where This Fits In
This review provides a new framework. It’s called “mechano-immunology.” It’s the idea that to treat keloids, we need to address both the mechanical forces and the immune response.
“We used to think of inflammation and mechanical tension as separate problems,” one expert might say. “Now we see they are two sides of the same coin. You can’t fix one without addressing the other.”
This doesn’t mean we have a new cure today. But it gives scientists a clearer map for where to look. It suggests that treatments targeting both inflammation and tension might work better than current options.
If you or someone you know has keloids, this research is hopeful but not a quick fix. It explains why current treatments can be frustrating. It also points to why some new approaches, like tension-reduction techniques or drugs that target specific inflammatory pathways (like JAK/STAT or IL-4/IL-13), are being studied.
You should not change your treatment plan based on this review. But you can talk to your doctor about the role of tension. For example, after surgery, using silicone sheets or tape to reduce tension on the wound might help. This is a low-risk strategy that some doctors already recommend.
This review is a summary of existing knowledge, not a new clinical trial. The next step is to test therapies that target both mechanics and inflammation. Researchers need to design studies that combine tension-reduction methods with anti-inflammatory drugs.
It takes time to move from theory to treatment. New therapies must go through clinical trials to prove they are safe and effective. But this review gives researchers a solid foundation to build on. The goal is more personalized, effective care for people with keloids.
